Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 16 of 23

Cannabis Science, Inc. Initiates the Scientific Validation of the Biological Impact of Cannabinoids in Order to Better Define the Therapeutic Mechanism of Action Using Biochemical, Cell, and Genetic Approaches

Created on 2018-06-11 17:38:39

Mark Wainberg, Ph.D., Joins Cannabis Science's Scientific Advisory Board; Cannabis Science Presents Further Dimensions of CS-TATI-1 Discovery Platform at 8th IAS Conference on HIV Pathogenesis

Created on 2018-06-11 17:35:19

Gulf Onshore Announces Name Change to Cannabis Science, Inc. and Selection of Its First Pharmaceutical Cannabis Product for FDA Testing

Created on 2018-06-10 09:47:58

Cannabis Science Outlines Objectives For The New Year; Highlights Include Moving Towards Contracts and Licensing Agreements For Research and Development of New Medicines

Created on 2018-06-10 09:46:47

Cannabis Science Extracts Kill Cancer Cells In Cancer Patients Being Treated Through Its Licensed Distributor Rockbrook

Created on 2018-06-10 09:45:37

Cannabis Science, Inc., World AIDS Institute and Timothy Ray Brown Foundation Hold Special Event Tomorrow, December 15, in Las Vegas: 'All I Want For Christmas is a Cure'

Created on 2018-06-10 09:44:09

Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative

Created on 2018-06-10 09:42:55

Cannabis Science (CBIS) Ready For A Prosperous And Healthy New Year: 'The Best Is Yet To Come'

Created on 2018-06-10 09:41:41

Cannabis Science Signs Gary Blick, MD and Proceeds With CS-TATI-1 for HIV and Kaposi Sarcoma Drug Development Program

Created on 2018-06-10 09:29:31

Cannabis Science Announces Pharmaceutical Development of Pain Patch For Patients with Diabetic Nerve Pain and Fibromyalgia

Created on 2018-06-10 09:12:02

Cannabis Science to Begin In-House Clinical Research With IGXBio's GenePro FDA Investigational New Drug (IND) Number 015982 for further Drug Development to Identify & Develop Agonist Cannabinoids for GenePro

Created on 2018-06-10 09:11:03

Cannabis Science Urges Shareholders to Vote for Cannabis Legalization and Regulation, Nationwide

Created on 2018-06-10 09:09:52

CBIS CEO, Mr. Dabney Prepares for Exclusive Harvard Medical School Drug Development Briefing as the Nation Votes on a Number of Historic Events

Created on 2018-06-10 09:08:37

Cannabis Science Congratulates our 45th President, Mr. Donald J. Trump and Moves Forward Strong as California, Nevada, and Massachusetts all Legalize Marijuana for Adult Use Praising all Voters for Furthering the Nationwide Cannabis Movement

Created on 2018-06-10 09:07:21

Cannabis Science Targets Rapid Expansion as it Opens New Negotiations for over 1,000 Acres Targeting Property/Drug Development in California and Nevada as Industry Opens Up

Created on 2018-06-10 09:06:20

Cannabis Science Begins Buildout of 33,000 Sq. Ft. Greenhouse Space for its First Douglas County, Nevada Cannabinoid Drug Development Land Deal

Created on 2018-06-10 09:05:16

Cannabis Science Announces Initiation of Studies into Intravenous Therapy (IV) Transfer of CBD/THC Rich Extracts for Pulmonary Patients

Created on 2018-06-10 09:04:11

Harvard Director of Global Health Catalyst at the World-Renowned Dana Farber/Harvard Cancer Center States: Cannabis Science Presentation and Discussions a Great Success for Mutually Beneficial Partnership Opportunities with Harvard Medical School

Created on 2018-06-10 09:02:59

Cannabis Science Orders Multiple Greenhouse Structures for its 2nd Pilot 33,000 Sq. Ft. Drug Development Facility Buildout in Douglas County, Nevada

Created on 2018-06-10 09:01:30

Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’

Created on 2018-06-10 08:39:03

  • Start
  • Prev
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.